High-frequency oscillations

Last updated
Example of the high-frequency oscillation burst recorded from the brain. HFO wiki.jpg
Example of the high-frequency oscillation burst recorded from the brain.

High-frequency oscillations (HFO) are brain waves of the frequency faster than ~80 Hz, generated by neuronal cell population. High-frequency oscillations can be recorded during an electroencephalagram (EEG), local field potential (LFP) or electrocorticogram (ECoG) electrophysiology recordings. They are present in physiological state during sharp waves and ripples - oscillatory patterns involved in memory consolidation processes. [1] HFOs are associated with pathophysiology of the brain like epileptic seizure [2] and are often recorded during seizure onset. It makes a promising biomarker for the identification of the epileptogenic zone. [3] [4] Other studies points to the HFO role in psychiatric disorders and possible implications to psychotic episodes in schizophrenia. [5] [6] [7]

Contents

Background and history

Traditional classification of the frequency bands, that are associated to different functions/states of the brain and consist of delta, theta, alpha, beta and gamma bands. Due to the limited capabilities of the early experimental/medical setup to record fast frequencies, for historical reason, all oscillations above 30 Hz were considered as high frequency and were difficult to investigate. [1] Recent advance in manufacturing electrophysiological setups enables to record electric potential with high temporal and space resolution, and to "catch" dynamics of single cell action potential. In neuroscience nomenclature, there is still a reaming gap between ~100 Hz and multi unit activity (>500 Hz), so these oscillations are often called high gamma or HFO.

Neurophysiological features

HFO are generated by different cellular mechanisms and can be detected in many brain areas. [8] [9] In hippocampus, this fast neuronal activity is effect of the population synchronous spiking of pyramidal cells in the CA3 region and dendritic layer of the CA1, which give rise to a characteristic oscillation pattern (see more in sharp waves and ripples). [10] The HFO occurrence during memory task (encoding and recalling images) was also reported in human patients from intracranial recordings in primary visual, limbic and higher order cortical areas. [11] Another example of physiological HFO of around 300 Hz, was found in subthalamic nucleus, [12] the brain region which is the main target for high-frequency (130 Hz) deep brain stimulation treatment for patients with Parkinson's disease.  

Somatosensory evoked high-frequency oscillations

ECoG recordings from human somatosensory cortex, has shown HFO (reaching even 600 Hz) presence during sensory evoked potentials and somatosensory evoked magnetic field after median nerve stimulation. [13] These bursts of activity are generated by thalamocortical loop and driven by highly synchronized spiking of the thalamocortical fibres, and are thought to play a role in information processing. [14] Somatosensory evoked HFO amplitude changes may be potentially used as biomarker for neurologic disorders, which can help in diagnosis in certain clinical contexts. Some oncology patients with brain tumors showed higher HFOs amplitude on the same side, where the tumor was. Authors of this study also suggest contribution from the thalamocortical pathways to the fast oscillations. [15] Interestingly, higher HFO amplitudes (between 400 and 800 Hz) after nerve stimulation were also reported in the EEG signal of healthy football and racquet sports players. [16]

Pathological HFO

There are many studies, that reports pathophysiological types of HFO in human patients and animal models of disease, which are related to different psychiatric or neurological disorders:

NMDA receptor hypofunction HFO

Current source density reconstruction (done with kCSD method, red and blue dots) of the example HFO burst recorded (6 channel setup - green dots) from rat's brain (grey dots). Hfo rat.gif
Current source density reconstruction (done with kCSD method, red and blue dots) of the example HFO burst recorded (6 channel setup - green dots) from rat's brain (grey dots).

There are increasing number of studies indicating that HFO rhythms (130–180 Hz) may arise due to the local NMDA receptor blockage, [25] [26] [27] [28] which is also a pharmacological model of schizophrenia. [26] These NMDA receptor dependent fast oscillations were detected in different brain areas including hippocampus, [29] nucleus accumbens [6] and prefrontal cortex regions. [30] Despite the fact that this type of HFO was not yet confirmed in human patients, second generation antipsychotic drugs, widely used to treat schizophrenia and schizoaffective disorders (i.e. Clozapine, Risperidone), were shown to reduce HFO frequency. [6] Recent studies, reports on the new source of HFO in the olfactory bulb structures, which is surprisingly stronger than any other previously seen in the mammalian brain. [31] [32] HFO in the bulb is generated by local excitatory-inhibitory circuits modulated by breathing rhythm and may be also recorded under ketamine-xylazine anesthesia. [33] This findings may aid understanding early symptoms of schizophrenia patients and their relatives, that can suffer from olfactory system impairments. [34]

See also

Brain waves

Related Research Articles

<span class="mw-page-title-main">Phencyclidine</span> Dissociative hallucinogenic drug, mostly used recreationally

Phencyclidine or phenylcyclohexyl piperidine (PCP), also known as angel dust among other names, is a dissociative anesthetic mainly used recreationally for its significant mind-altering effects. PCP may cause hallucinations, distorted perceptions of sounds, and violent behavior. As a recreational drug, it is typically smoked, but may be taken by mouth, snorted, or injected. It may also be mixed with cannabis or tobacco.

<span class="mw-page-title-main">Magnetoencephalography</span> Mapping brain activity by recording magnetic fields produced by currents in the brain

Magnetoencephalography (MEG) is a functional neuroimaging technique for mapping brain activity by recording magnetic fields produced by electrical currents occurring naturally in the brain, using very sensitive magnetometers. Arrays of SQUIDs are currently the most common magnetometer, while the SERF magnetometer is being investigated for future machines. Applications of MEG include basic research into perceptual and cognitive brain processes, localizing regions affected by pathology before surgical removal, determining the function of various parts of the brain, and neurofeedback. This can be applied in a clinical setting to find locations of abnormalities as well as in an experimental setting to simply measure brain activity.

An evoked potential or evoked response is an electrical potential in a specific pattern recorded from a specific part of the nervous system, especially the brain, of a human or other animals following presentation of a stimulus such as a light flash or a pure tone. Different types of potentials result from stimuli of different modalities and types. Evoked potential is distinct from spontaneous potentials as detected by electroencephalography (EEG), electromyography (EMG), or other electrophysiologic recording method. Such potentials are useful for electrodiagnosis and monitoring that include detections of disease and drug-related sensory dysfunction and intraoperative monitoring of sensory pathway integrity.

<span class="mw-page-title-main">Delta wave</span> High amplitude low frequency brain wave

Delta waves are high amplitude neural oscillations with a frequency between 0.5 and 4 hertz. Delta waves, like other brain waves, can be recorded with electroencephalography (EEG) and are usually associated with the deep stage 3 of NREM sleep, also known as slow-wave sleep (SWS), and aid in characterizing the depth of sleep. Suppression of delta waves leads to inability of body rejuvenation, brain revitalization and poor sleep.

<span class="mw-page-title-main">Dizocilpine</span> Chemical compound

Dizocilpine (INN), also known as MK-801, is a pore blocker of the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor, discovered by a team at Merck in 1982. Glutamate is the brain's primary excitatory neurotransmitter. The channel is normally blocked with a magnesium ion and requires depolarization of the neuron to remove the magnesium and allow the glutamate to open the channel, causing an influx of calcium, which then leads to subsequent depolarization. Dizocilpine binds inside the ion channel of the receptor at several of PCP's binding sites thus preventing the flow of ions, including calcium (Ca2+), through the channel. Dizocilpine blocks NMDA receptors in a use- and voltage-dependent manner, since the channel must open for the drug to bind inside it. The drug acts as a potent anti-convulsant and probably has dissociative anesthetic properties, but it is not used clinically for this purpose because of the discovery of brain lesions, called Olney's lesions (see below), in laboratory rats. Dizocilpine is also associated with a number of negative side effects, including cognitive disruption and psychotic-spectrum reactions. It inhibits the induction of long term potentiation and has been found to impair the acquisition of difficult, but not easy, learning tasks in rats and primates. Because of these effects of dizocilpine, the NMDA receptor pore blocker ketamine is used instead as a dissociative anesthetic in human medical procedures. While ketamine may also trigger temporary psychosis in certain individuals, its short half-life and lower potency make it a much safer clinical option. However, dizocilpine is the most frequently used uncompetitive NMDA receptor antagonist in animal models to mimic psychosis for experimental purposes.

A gamma wave or gamma rhythm is a pattern of neural oscillation in humans with a frequency between 25 and 140 Hz, the 40 Hz point being of particular interest. Gamma rhythms are correlated with large scale brain network activity and cognitive phenomena such as working memory, attention, and perceptual grouping, and can be increased in amplitude via meditation or neurostimulation. Altered gamma activity has been observed in many mood and cognitive disorders such as Alzheimer's disease, epilepsy, and schizophrenia. Elevated gamma activity has also been observed in moments preceding death.

Sleep spindles are bursts of neural oscillatory activity that are generated by interplay of the thalamic reticular nucleus (TRN) and other thalamic nuclei during stage 2 NREM sleep in a frequency range of ~11 to 16 Hz with a duration of 0.5 seconds or greater. After generation as an interaction of the TRN neurons and thalamocortical cells, spindles are sustained and relayed to the cortex by thalamo-thalamic and thalamo-cortical feedback loops regulated by both GABAergic and NMDA-receptor mediated glutamatergic neurotransmission. Sleep spindles have been reported for all tested mammalian species. Considering animals in which sleep-spindles were studied extensively, they appear to have a conserved main frequency of roughly 9–16 Hz. Only in humans, rats and dogs is a difference in the intrinsic frequency of frontal and posterior spindles confirmed, however.

Alpha waves, or the alpha rhythm, are neural oscillations in the frequency range of 8–12 Hz likely originating from the synchronous and coherent electrical activity of thalamic pacemaker cells in humans. Historically, they are also called "Berger's waves" after Hans Berger, who first described them when he invented the EEG in 1924.

Brainwave entrainment, also referred to as brainwave synchronization or neural entrainment, refers to the observation that brainwaves will naturally synchronize to the rhythm of periodic external stimuli, such as flickering lights, speech, music, or tactile stimuli.

<span class="mw-page-title-main">Neural oscillation</span> Brainwaves, repetitive patterns of neural activity in the central nervous system

Neural oscillations, or brainwaves, are rhythmic or repetitive patterns of neural activity in the central nervous system. Neural tissue can generate oscillatory activity in many ways, driven either by mechanisms within individual neurons or by interactions between neurons. In individual neurons, oscillations can appear either as oscillations in membrane potential or as rhythmic patterns of action potentials, which then produce oscillatory activation of post-synaptic neurons. At the level of neural ensembles, synchronized activity of large numbers of neurons can give rise to macroscopic oscillations, which can be observed in an electroencephalogram. Oscillatory activity in groups of neurons generally arises from feedback connections between the neurons that result in the synchronization of their firing patterns. The interaction between neurons can give rise to oscillations at a different frequency than the firing frequency of individual neurons. A well-known example of macroscopic neural oscillations is alpha activity.

Theta waves generate the theta rhythm, a neural oscillation in the brain that underlies various aspects of cognition and behavior, including learning, memory, and spatial navigation in many animals. It can be recorded using various electrophysiological methods, such as electroencephalogram (EEG), recorded either from inside the brain or from electrodes attached to the scalp.

Sensory gating describes neural processes of filtering out redundant or irrelevant stimuli from all possible environmental stimuli reaching the brain. Also referred to as gating or filtering, sensory gating prevents an overload of information in the higher cortical centers of the brain. Sensory gating can also occur in different forms through changes in both perception and sensation, affected by various factors such as "arousal, recent stimulus exposure, and selective attention.

<span class="mw-page-title-main">Electrocorticography</span>

Electrocorticography (ECoG), a type of intracranial electroencephalography (iEEG), is a type of electrophysiological monitoring that uses electrodes placed directly on the exposed surface of the brain to record electrical activity from the cerebral cortex. In contrast, conventional electroencephalography (EEG) electrodes monitor this activity from outside the skull. ECoG may be performed either in the operating room during surgery or outside of surgery. Because a craniotomy is required to implant the electrode grid, ECoG is an invasive procedure.

<span class="mw-page-title-main">Mu wave</span> Electrical activity in the part of the brain controlling voluntary movement

The sensorimotor mu rhythm, also known as mu wave, comb or wicket rhythms or arciform rhythms, are synchronized patterns of electrical activity involving large numbers of neurons, probably of the pyramidal type, in the part of the brain that controls voluntary movement. These patterns as measured by electroencephalography (EEG), magnetoencephalography (MEG), or electrocorticography (ECoG), repeat at a frequency of 7.5–12.5 Hz, and are most prominent when the body is physically at rest. Unlike the alpha wave, which occurs at a similar frequency over the resting visual cortex at the back of the scalp, the mu rhythm is found over the motor cortex, in a band approximately from ear to ear. People suppress mu rhythms when they perform motor actions or, with practice, when they visualize performing motor actions. This suppression is called desynchronization of the wave because EEG wave forms are caused by large numbers of neurons firing in synchrony. The mu rhythm is even suppressed when one observes another person performing a motor action or an abstract motion with biological characteristics. Researchers such as V. S. Ramachandran and colleagues have suggested that this is a sign that the mirror neuron system is involved in mu rhythm suppression, although others disagree.

<span class="mw-page-title-main">Spike-and-wave</span>

Spike-and-wave is a pattern of the electroencephalogram (EEG) typically observed during epileptic seizures. A spike-and-wave discharge is a regular, symmetrical, generalized EEG pattern seen particularly during absence epilepsy, also known as ‘petit mal’ epilepsy. The basic mechanisms underlying these patterns are complex and involve part of the cerebral cortex, the thalamocortical network, and intrinsic neuronal mechanisms.

Ponto-geniculo-occipital waves or PGO waves are distinctive wave forms of propagating activity between three key brain regions: the pons, lateral geniculate nucleus, and occipital lobe; specifically, they are phasic field potentials. These waves can be recorded from any of these three structures during and immediately before REM sleep. The waves begin as electrical pulses from the pons, then move to the lateral geniculate nucleus residing in the thalamus, and end in the primary visual cortex of the occipital lobe. The appearances of these waves are most prominent in the period right before REM sleep, albeit they have been recorded during wakefulness as well. They are theorized to be intricately involved with eye movement of both wake and sleep cycles in many different animals.

<span class="mw-page-title-main">Electroencephalography</span> Electrophysiological monitoring method to record electrical activity of the brain

Electroencephalography (EEG) is a method to record an electrogram of the spontaneous electrical activity of the brain. The biosignals detected by EEG have been shown to represent the postsynaptic potentials of pyramidal neurons in the neocortex and allocortex. It is typically non-invasive, with the EEG electrodes placed along the scalp using the International 10–20 system, or variations of it. Electrocorticography, involving surgical placement of electrodes, is sometimes called "intracranial EEG". Clinical interpretation of EEG recordings is most often performed by visual inspection of the tracing or quantitative EEG analysis.

In neuroscience, the N100 or N1 is a large, negative-going evoked potential measured by electroencephalography ; it peaks in adults between 80 and 120 milliseconds after the onset of a stimulus, and is distributed mostly over the fronto-central region of the scalp. It is elicited by any unpredictable stimulus in the absence of task demands. It is often referred to with the following P200 evoked potential as the "N100-P200" or "N1-P2" complex. While most research focuses on auditory stimuli, the N100 also occurs for visual, olfactory, heat, pain, balance, respiration blocking, and somatosensory stimuli.

The P3a, or novelty P3, is a component of time-locked (EEG) signals known as event-related potentials (ERP). The P3a is a positive-going scalp-recorded brain potential that has a maximum amplitude over frontal/central electrode sites with a peak latency falling in the range of 250–280 ms. The P3a has been associated with brain activity related to the engagement of attention and the processing of novelty.

Pain empathy is a specific variety of empathy that involves recognizing and understanding another person's pain.

References

  1. 1 2 Buzsáki, György; da Silva, Fernando Lopes (September 2012). "High frequency oscillations in the intact brain". Progress in Neurobiology. 98 (3): 241–249. doi:10.1016/j.pneurobio.2012.02.004. ISSN   0301-0082. PMC   4895831 . PMID   22449727.
  2. ↑ Engel, Jerome; Bragin, Anatol; Staba, Richard; Mody, Istvan (April 2009). "High-frequency oscillations: what is normal and what is not?". Epilepsia. 50 (4): 598–604. doi: 10.1111/j.1528-1167.2008.01917.x . ISSN   1528-1167. PMID   19055491. S2CID   18528403.
  3. ↑ Jacobs, J.; Staba, R.; Asano, E.; Otsubo, H.; Wu, J.Y.; Zijlmans, M.; Mohamed, I.; Kahane, P.; Dubeau, F.; Navarro, V.; Gotman, J. (September 2012). "High-frequency oscillations (HFOs) in clinical epilepsy". Progress in Neurobiology. 98 (3): 302–315. doi:10.1016/j.pneurobio.2012.03.001. ISSN   0301-0082. PMC   3674884 . PMID   22480752.
  4. ↑ Arroyo, Santiago; Uematsu, Sumio (July 1992). "High-Frequency EEG Activity at the Start of Seizures". Journal of Clinical Neurophysiology. 9 (3): 441–448. doi:10.1097/00004691-199207010-00012. ISSN   0736-0258. PMID   1517412.
  5. ↑ Uhlhaas, Peter J.; Singer, Wolf (September 2013). "High-frequency oscillations and the neurobiology of schizophrenia". Dialogues in Clinical Neuroscience. 15 (3): 301–313. doi:10.31887/DCNS.2013.15.3/puhlhaas. ISSN   1294-8322. PMC   3811102 . PMID   24174902.
  6. 1 2 3 4 Olszewski, Maciej; Piasecka, Joanna; Goda, Sailaja A.; Kasicki, Stefan; Hunt, Mark J. (June 2013). "Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs". The International Journal of Neuropsychopharmacology. 16 (5): 1009–1020. doi: 10.1017/S1461145712001034 . ISSN   1469-5111. PMID   23171738.
  7. ↑ Goda, Sailaja A.; Olszewski, Maciej; Piasecka, Joanna; Rejniak, Karolina; Whittington, Miles A.; Kasicki, Stefan; Hunt, Mark J. (August 2015). "Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 61: 44–51. doi:10.1016/j.pnpbp.2015.03.016. ISSN   0278-5846. PMID   25862088. S2CID   13965042.
  8. ↑ Haufler, Darrell; Pare, Denis (2014-07-01). "High-frequency oscillations are prominent in the extended amygdala". Journal of Neurophysiology. 112 (1): 110–119. doi:10.1152/jn.00107.2014. ISSN   0022-3077. PMC   4064387 . PMID   24717353.
  9. ↑ Zhong, Weiwei; Ciatipis, Mareva; Wolfenstetter, Thérèse; Jessberger, Jakob; Müller, Carola; Ponsel, Simon; Yanovsky, Yevgenij; Brankačk, Jurij; Tort, Adriano B. L.; Draguhn, Andreas (2017-04-25). "Selective entrainment of gamma subbands by different slow network oscillations". Proceedings of the National Academy of Sciences of the United States of America. 114 (17): 4519–4524. doi: 10.1073/pnas.1617249114 . ISSN   0027-8424. PMC   5410835 . PMID   28396398.
  10. ↑ Ylinen, A.; Bragin, A.; Nádasdy, Z.; Jandó, G.; Szabó, I.; Sik, A.; Buzsáki, G. (January 1995). "Sharp wave-associated high-frequency oscillation (200 Hz) in the intact hippocampus: network and intracellular mechanisms". The Journal of Neuroscience. 15 (1 Pt 1): 30–46. doi:10.1523/JNEUROSCI.15-01-00030.1995. ISSN   0270-6474. PMC   6578299 . PMID   7823136.
  11. ↑ Kucewicz, Michal T.; Cimbalnik, Jan; Matsumoto, Joseph Y.; Brinkmann, Benjamin H.; Bower, Mark R.; Vasoli, Vincent; Sulc, Vlastimil; Meyer, Fred; Marsh, W. R.; Stead, S. M.; Worrell, Gregory A. (August 2014). "High frequency oscillations are associated with cognitive processing in human recognition memory". Brain. 137 (8): 2231–2244. doi:10.1093/brain/awu149. ISSN   0006-8950. PMC   4107742 . PMID   24919972.
  12. 1 2 Foffani, G. (2003-06-23). "300-Hz subthalamic oscillations in Parkinson's disease". Brain. 126 (10): 2153–2163. doi: 10.1093/brain/awg229 . ISSN   1460-2156. PMID   12937087.
  13. ↑ Burnos, Sergey; Fedele, Tommaso; Schmid, Olivier; Krayenbühl, Niklaus; Sarnthein, Johannes (2016-01-01). "Detectability of the somatosensory evoked high frequency oscillation (HFO) co-recorded by scalp EEG and ECoG under propofol". NeuroImage: Clinical. 10: 318–325. doi:10.1016/j.nicl.2015.11.018. ISSN   2213-1582. PMC   4723731 . PMID   26900572.
  14. ↑ Ozaki, Isamu; Hashimoto, Isao (2011-10-01). "Exploring the physiology and function of high-frequency oscillations (HFOs) from the somatosensory cortex". Clinical Neurophysiology. 122 (10): 1908–1923. doi:10.1016/j.clinph.2011.05.023. ISSN   1388-2457. PMID   21724458. S2CID   7628474.
  15. ↑ Ooba, Hiroshi; Abe, Tatsuya; Kamida, Tohru; Anan, Mitsuhiro; Morishige, Masaki; Fujiki, Minoru (April 2010). "Increasing high-frequency oscillations (HFOs) in patients with brain tumours: implication for increasing amplitude of N20". Clinical Neurophysiology. 121 (4): 474–481. doi:10.1016/j.clinph.2009.12.007. ISSN   1872-8952. PMID   20097127. S2CID   206793052.
  16. ↑ Murakami, Takenobu; Sakuma, Kenji; Nakashima, Kenji (2008-12-01). "Somatosensory evoked potentials and high-frequency oscillations in athletes". Clinical Neurophysiology. 119 (12): 2862–2869. doi:10.1016/j.clinph.2008.09.002. ISSN   1388-2457. PMID   18849191. S2CID   30129908.
  17. ↑ Gobbelé, René; Waberski, Till Dino; Dieckhöfer, Anne; Kawohl, Wolfram; Klostermann, Fabian; Curio, Gabriel; Buchner, Helmut (July 2003). "Patterns of disturbed impulse propagation in multiple sclerosis identified by low and high frequency somatosensory evoked potential components". Journal of Clinical Neurophysiology. 20 (4): 283–290. doi:10.1097/00004691-200307000-00008. ISSN   0736-0258. PMID   14530742. S2CID   24099633.
  18. ↑ Zijlmans, Maeike; Jiruska, Premysl; Zelmann, Rina; Leijten, Frans S. S.; Jefferys, John G. R.; Gotman, Jean (February 2012). "High-frequency oscillations as a new biomarker in epilepsy". Annals of Neurology. 71 (2): 169–178. doi:10.1002/ana.22548. ISSN   1531-8249. PMC   3754947 . PMID   22367988.
  19. ↑ Frauscher, Birgit; Bartolomei, Fabrice; Kobayashi, Katsuhiro; Cimbalnik, Jan; van't Klooster, Maryse A.; Rampp, Stefan; Otsubo, Hiroshi; Höller, Yvonne; Wu, Joyce Y.; Asano, Eishi; Engel, Jerome (August 2017). "High-frequency oscillations: The state of clinical research". Epilepsia. 58 (8): 1316–1329. doi:10.1111/epi.13829. ISSN   0013-9580. PMC   5806699 . PMID   28666056.
  20. ↑ Yang, Andrew I.; Vanegas, Nora; Lungu, Codrin; Zaghloul, Kareem A. (2014-09-17). "Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease". The Journal of Neuroscience. 34 (38): 12816–12827. doi:10.1523/JNEUROSCI.1895-14.2014. ISSN   1529-2401. PMC   4166162 . PMID   25232117.
  21. ↑ Borjigin, Jimo; Lee, UnCheol; Liu, Tiecheng; Pal, Dinesh; Huff, Sean; Klarr, Daniel; Sloboda, Jennifer; Hernandez, Jason; Wang, Michael M.; Mashour, George A. (2013-08-27). "Surge of neurophysiological coherence and connectivity in the dying brain". Proceedings of the National Academy of Sciences of the United States of America. 110 (35): 14432–14437. Bibcode:2013PNAS..11014432B. doi: 10.1073/pnas.1308285110 . ISSN   1091-6490. PMC   3761619 . PMID   23940340.
  22. ↑ Hunt, Mark J.; Olszewski, Maciej; Piasecka, Joanna; Whittington, Miles A.; Kasicki, Stefan (2015). "Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice". Psychopharmacology. 232 (24): 4525–4535. doi:10.1007/s00213-015-4073-0. ISSN   0033-3158. PMC   4646921 . PMID   26446869.
  23. ↑ Hunt, Mark J; Kasicki, Stefan (2013-07-17). "A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo". Journal of Psychopharmacology. 27 (11): 972–986. doi:10.1177/0269881113495117. ISSN   0269-8811. PMID   23863924. S2CID   31344362.
  24. ↑ Chintaluri, Chaitanya; Bejtka, Marta; Średniawa, Władysław; Czerwiński, Michał; Dzik, Jakub M.; Jędrzejewska-Szmek, Joanna; Kondrakiewicz, Kacper; Kublik, Ewa; Wójcik, Daniel K. (2021-05-14). "What we can and what we cannot see with extracellular multielectrodes". PLOS Computational Biology. 17 (5): e1008615. Bibcode:2021PLSCB..17E8615C. doi: 10.1371/journal.pcbi.1008615 . ISSN   1553-7358. PMC   8153483 . PMID   33989280.
  25. ↑ Hunt, Mark Jeremy; Raynaud, Beryl; Garcia, Rene (2006-12-01). "Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats". Biological Psychiatry. 60 (11): 1206–1214. doi:10.1016/j.biopsych.2006.01.020. ISSN   0006-3223. PMID   16650831. S2CID   22548264.
  26. 1 2 Frohlich, Joel; Van Horn, John D. (April 2014). "Reviewing the ketamine model for schizophrenia". Journal of Psychopharmacology. 28 (4): 287–302. doi:10.1177/0269881113512909. ISSN   1461-7285. PMC   4133098 . PMID   24257811.
  27. ↑ Phillips, K.G.; Cotel, M.C.; McCarthy, A.P.; Edgar, D.M.; Tricklebank, M.; O'Neill, M.J.; Jones, M.W.; Wafford, K.A. (March 2012). "Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia". Neuropharmacology. 62 (3): 1359–1370. doi:10.1016/j.neuropharm.2011.04.006. PMID   21521646. S2CID   23058003.
  28. ↑ Hansen, Ingeborg H.; Agerskov, Claus; Arvastson, Lars; Bastlund, Jesper F.; Sørensen, Helge B. D.; Herrik, Kjartan F. (July 2019). "Pharmaco-electroencephalographic responses in the rat differ between active and inactive locomotor states". The European Journal of Neuroscience. 50 (2): 1948–1971. doi:10.1111/ejn.14373. ISSN   1460-9568. PMC   6806018 . PMID   30762918.
  29. ↑ Caixeta, Fábio V.; Cornélio, Alianda M.; Scheffer-Teixeira, Robson; Ribeiro, Sidarta; Tort, Adriano B. L. (2013-08-02). "Ketamine alters oscillatory coupling in the hippocampus". Scientific Reports. 3: 2348. Bibcode:2013NatSR...3E2348C. doi:10.1038/srep02348. ISSN   2045-2322. PMC   3731648 . PMID   23907109.
  30. ↑ Pittman-Polletta, Benjamin; Hu, Kun; Kocsis, Bernat (2018-08-02). "Subunit-specific NMDAR antagonism dissociates schizophrenia subtype-relevant oscillopathies associated with frontal hypofunction and hippocampal hyperfunction". Scientific Reports. 8 (1): 11588. Bibcode:2018NatSR...811588P. doi:10.1038/s41598-018-29331-8. ISSN   2045-2322. PMC   6072790 . PMID   30072757.
  31. ↑ Hunt, Mark Jeremy; Adams, Natalie E.; Średniawa, Władysław; Wójcik, Daniel K.; Simon, Anna; Kasicki, Stefan; Whittington, Miles Adrian (January 2019). "The olfactory bulb is a source of high-frequency oscillations (130–180 Hz) associated with a subanesthetic dose of ketamine in rodents". Neuropsychopharmacology. 44 (2): 435–442. doi: 10.1038/s41386-018-0173-y . ISSN   1740-634X. PMC   6300534 . PMID   30140046.
  32. ↑ Wróbel, Jacek; Średniawa, Władysław; Jurkiewicz, Gabriela; Żygierewicz, Jarosław; Wójcik, Daniel K.; Whittington, Miles Adrian; Hunt, Mark Jeremy (2020-11-04). "Nasal respiration is necessary for ketamine-dependent high frequency network oscillations and behavioral hyperactivity in rats". Scientific Reports. 10 (1): 18981. Bibcode:2020NatSR..1018981W. doi: 10.1038/s41598-020-75641-1 . ISSN   2045-2322. PMC   7642442 . PMID   33149202.
  33. ↑ Średniawa, Władysław; Wróbel, Jacek; Kublik, Ewa; Wójcik, Daniel Krzysztof; Whittington, Miles Adrian; Hunt, Mark Jeremy (2021-03-18). "Network and synaptic mechanisms underlying high frequency oscillations in the rat and cat olfactory bulb under ketamine-xylazine anesthesia". Scientific Reports. 11 (1): 6390. doi: 10.1038/s41598-021-85705-5 . ISSN   2045-2322. PMC   7973548 . PMID   33737621.
  34. ↑ Turetsky, Bruce I; Hahn, Chang-Gyu; Arnold, Steven E; Moberg, Paul J (February 2009). "Olfactory Receptor Neuron Dysfunction in Schizophrenia". Neuropsychopharmacology. 34 (3): 767–774. doi:10.1038/npp.2008.139. ISSN   0893-133X. PMC   3524971 . PMID   18754006.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.